Cost Effectiveness of Optifast® LCD As Compared with Liraglutide 3 Mg And “No Intervention” In Switzerland

Title
Cost Effectiveness of Optifast® LCD As Compared with Liraglutide 3 Mg And “No Intervention” In Switzerland
Authors
Keywords
-
Journal
VALUE IN HEALTH
Volume 20, Issue 9, Pages A554-A555
Publisher
Elsevier BV
Online
2017-10-20
DOI
10.1016/j.jval.2017.08.885

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now